SP2 Therapeutics is redefining peptide synthesis, addressing core biopharmaceutical production challenges. Our patent-protected FLOWSMART system combines Nobel-prize winning solid phase peptide synthesis with AI-guided, resin-based flow chemistry, achieving massive cost savings and scalability. SP2 Therapeutics is a spinout from Seoul National University's renowned Institute of Molecular Biology and Genetics. Our core team’s expertise spans diverse domains such as resin-based chemistry, bioinformatics, engineering, and machine learning. Our FLOWSMART synthesis platform can greatly accelerate your peptide drug development efforts.

SP2TX

Org chart

Teams

Offices

SP2TX

Org chart

Teams

Offices

Related companies